AAAAAA

   
Results: 1-24 |
Results: 24

Authors: Hermesh, H Manor, I Shiloh, R Weizman, R Munitz, H
Citation: H. Hermesh et al., Absence of myoglobinuria in acute psychotic patients with marked elevationin serum creatine phosphokinase level, EUR NEUROPS, 11(2), 2001, pp. 111-115

Authors: Toren, P Eldar, S Laor, N Wolmer, L Samuel, E Weizman, R
Citation: P. Toren et al., Fluvoxamine is ineffective in the treatment of enuresis in children and adolescents: an open-label pilot study, HUM PSYCHOP, 16(4), 2001, pp. 327-332

Authors: Weizman, R Paz, L Peter, Y Pick, CG
Citation: R. Weizman et al., Mice performance on the staircase test following acute ethanol administration, PHARM BIO B, 68(3), 2001, pp. 491-495

Authors: Weizman, R Paz, L Peter, Y Toren, P Pick, CG
Citation: R. Weizman et al., Behavioral effects of agents active at the gamma-aminobutyric acid receptor complex in the staircase paradigm, BRAIN RES, 901(1-2), 2001, pp. 137-142

Authors: Shamir, E Barak, Y Shalman, I Laudon, M Zisapel, N Tarrasch, R Elizur, A Weizman, R
Citation: E. Shamir et al., Melatonin treatment for tardive dyskinesia - A double-blind, placebo-controlled, crossover study, ARCH G PSYC, 58(11), 2001, pp. 1049-1052

Authors: Frisch, A Michaelovsky, E Rockah, R Amir, I Hermesh, H Laor, N Fuchs, C Zohar, J Lerer, B Buniak, SF Landa, S Poyurovsky, M Shapira, B Weizman, R
Citation: A. Frisch et al., Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways, EUR NEUROPS, 10(3), 2000, pp. 205-209

Authors: Toren, P Wolmer, L Rosental, B Eldar, S Koren, S Lask, M Weizman, R Leor, N
Citation: P. Toren et al., Case series: Brief parent-child group therapy for childhood anxiety disorders using a manual-based cognitive-behavioral technique, J AM A CHIL, 39(10), 2000, pp. 1309-1312

Authors: Toren, P Sadeh, M Wolmer, L Eldar, S Koren, S Weizman, R Laor, N
Citation: P. Toren et al., Neurocognitive correlates of anxiety disorders in children: A preliminary report, J ANXIETY D, 14(3), 2000, pp. 239-247

Authors: Leschiner, S Weizman, R Shoukrun, R Veenman, L Gavish, M
Citation: S. Leschiner et al., Tissue-specific regulation of the peripheral benzodiazepine receptor by antidepressants and lithium, NEUROPSYCHB, 42(3), 2000, pp. 127-134

Authors: Barak, Y Kimhi, R Weizman, R
Citation: Y. Barak et al., Is selectivity for serotonin uptake associated with a reduced emergence ofmanic episodes in depressed patients?, INT CLIN PS, 15(1), 2000, pp. 53-56

Authors: Laor, N Wolmer, L Wiener, Z Sharon, O Weizman, R Toren, P Ron, S
Citation: N. Laor et al., Image vividness as a psychophysiological regulator in posttraumatic stressdisorder, J CL EXP N, 21(1), 1999, pp. 39-48

Authors: Frisch, A Postilnick, D Rockah, R Michaelovsky, E Postilnick, S Birman, E Laor, N Rauchverger, B Kreinin, A Poyurovsky, M Schneidman, M Modai, I Weizman, R
Citation: A. Frisch et al., Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways, MOL PSYCHI, 4(4), 1999, pp. 389-392

Authors: Dror, V Shamir, E Ghanshani, S Kimhi, R Swartz, M Barak, Y Weizman, R Avivi, L Litmanovitch, T Fantino, E Kalman, K Jones, EG Chandy, KG Gargus, JJ Gutman, GA Navon, R
Citation: V. Dror et al., hKCa3/KCNN3 potassium channel gene: association of longer CAG repeats withschizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21, MOL PSYCHI, 4(3), 1999, pp. 254-260

Authors: Michaelovsky, E Frisch, A Rockah, R Peleg, L Magal, N Shohat, M Weizman, R
Citation: E. Michaelovsky et al., A novel allele in the promoter region of the human serotonin transporter gene, MOL PSYCHI, 4(1), 1999, pp. 97-99

Authors: Weizman, R Laor, N Wiener, Z Wolmer, L Bessler, H
Citation: R. Weizman et al., Cytokine production in panic disorder patients, CLIN NEUROP, 22(2), 1999, pp. 107-109

Authors: Weizman, R Lehmann, J Leschiner, S Allmann, I Stoehr, T Heidbreder, C Domeney, A Feldon, J Gavish, M
Citation: R. Weizman et al., Long-lasting effect of early handling on the peripheral benzodiazepine receptor, PHARM BIO B, 64(4), 1999, pp. 725-729

Authors: Schreiber, S Getslev, V Backer, MM Weizman, R Pick, CG
Citation: S. Schreiber et al., The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potency, PHARM BIO B, 64(1), 1999, pp. 75-80

Authors: Toren, P Eldar, S Cendorf, D Wolmer, L Weizman, R Zubadi, R Koren, S Laor, N
Citation: P. Toren et al., The prevalence of mitral valve prolapse in children with anxiety disorders, J PSYCH RES, 33(4), 1999, pp. 357-361

Authors: Laor, N Wolmer, L Wiener, Z Weizman, R Toren, P Ron, S
Citation: N. Laor et al., Image control and symptom expression in posttraumatic stress disorder, J NERV MENT, 187(11), 1999, pp. 673-679

Authors: Lehmann, J Weizman, R Pryce, CR Leschiner, S Allmann, I Feldon, J Gavish, M
Citation: J. Lehmann et al., Peripheral benzodiazepine receptors in cerebral cortex, but not in internal organs, are increased following inescapable stress and subsequent avoidance/escape shuttle-box testing, BRAIN RES, 851(1-2), 1999, pp. 141-147

Authors: Weizman, R Paz, L Backer, MM Amiri, Z Modai, I Pick, CG
Citation: R. Weizman et al., Mouse strains differ in their sensitivity to alprazolam effect in the staircase test, BRAIN RES, 839(1), 1999, pp. 58-65

Authors: Weizman, R Getslev, V Pankova, IA Schrieber, S Pick, CG
Citation: R. Weizman et al., Pharmacological interaction of the calcium channel blockers verapamil and flunarizine with the opioid system, BRAIN RES, 818(2), 1999, pp. 187-195

Authors: Nordenberg, J Fenig, E Landau, M Weizman, R Weizman, A
Citation: J. Nordenberg et al., Effects of psychotropic drugs on cell proliferation and differentiation, BIOCH PHARM, 58(8), 1999, pp. 1229-1236

Authors: Laor, N Wolmer, L Wiener, Z Reiss, A Muller, U Weizman, R Ron, S
Citation: N. Laor et al., The function of image control in the psychophysiology of posttraumatic stress disorder, J TRAUMA ST, 11(4), 1998, pp. 679-696
Risultati: 1-24 |